Apoptotic markers in cancer

Clinical Biochemistry
Stefan Holdenrieder, Petra Stieber

Abstract

In cancer, apoptotic processes occur both spontaneously and induced by antitumor therapies. Qualitative and quantitative changes in cancer cell death along with proliferative alterations are essential determinants in the pathogenesis and progression of malignant disease and its responsiveness to therapy. Besides detecting apoptosis by invasive means in tumor tissue, apoptotic products can be quantified in the circulation. Although circulating apoptotic products usually lack organ and tumor specificity, they contribute in the assessment of disease extent or aggressiveness. The ease of drawing blood facilitates the serial measurement of circulating apoptotic markers to monitor antitumor treatment and predict early response to therapy. This review describes the features of apoptotic and necrotic cell death along with the role the balance between the rates of cell death and cell proliferation plays in the progression of malignancy. The intracellular pathways mediating apoptosis are next summarized. The focus then shifts to the apoptotic markers found in the circulation and their diagnostic, prognostic, predictive, and management utility in cancer.

References

Dec 1, 1975·Journal of Immunological Methods·S A LeonB Shapiro
Apr 1, 1992·International Journal of Radiation Biology·R J CollinsJ F Kerr
Dec 1, 1987·The Journal of Pathology·A H Wyllie
Sep 1, 1971·The Journal of Pathology·J F Kerr
Oct 1, 1993·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·P StieberA Fateh-Moghadam
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·A H WyllieR G Morris
Nov 1, 1995·The Journal of Experimental Medicine·B VerhovenP Williamson
Aug 1, 1993·Cancer·P StieberA Fateh-Moghadam
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G Prindull
May 16, 1995·International Journal of Cancer. Journal International Du Cancer·J W WilsonC Dive
Jan 1, 1994·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·R MolinaA M Ballesta
Sep 7, 1994·Journal of the National Cancer Institute·B W Stewart
Apr 15, 1994·Cancer·J F KerrB V Harmon
Jan 8, 1996·FEBS Letters·C RichterC Franceschi
Feb 1, 1996·Anatomy and Embryology·P G Clarke, S Clarke
Sep 1, 1996·American Journal of Respiratory and Critical Care Medicine·J L PujolF B Michel
Jan 1, 1996·Gynecologic and Obstetric Investigation·K NasuI Miyakawa
Feb 7, 1997·Cell·S Nagata
Jan 1, 1997·Toxicologic Pathology·B F TrumpP C Phelps
Jan 1, 1997·The International Journal of Biochemistry & Cell Biology·A DesmoulièreG Gabbiani
Sep 1, 1997·Journal of the American Geriatrics Society·H R WarnerK Pocinki
May 2, 1998·The EMBO Journal·C ScaffidiM E Peter
Jul 11, 1998·Journal of Gastroenterology·T KashiharaK Tamaoka
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Sep 12, 1998·Science·J M Adams, S Cory
Oct 10, 1998·Respirology : Official Journal of the Asian Pacific Society of Respirology·H NakahamaM Sugita
Jan 23, 1999·Cell Death and Differentiation·B SingleP Nicotera
Feb 18, 1999·Toxicology Letters·P NicoteraE Ferrando-May
Mar 30, 1999·Experimental Cell Research·M Jäättelä
Jun 25, 1999·Cell Death and Differentiation·A SamaliS Orrenius
Aug 17, 1999·Seminars in Cancer Biology·K L Braithwaite, P H Rabbitts

❮ Previous
Next ❯

Citations

Jan 12, 2008·Cancer Immunology, Immunotherapy : CII·S H Beachy, E A Repasky
Sep 12, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Nikolaus KohlesStefan Holdenrieder
Sep 18, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Oliver J StoetzerStefan Holdenrieder
Feb 1, 2009·Biomarkers in Medicine·Stig Linder, Ayodele Alaiya
Jun 1, 2011·Radiology and Oncology·Engin UlukayaTürkkan Evrensel
Oct 1, 2008·Journal of Cancer Research and Clinical Oncology·Akemi OsakaShimeru Kamihira
Oct 16, 2013·Journal of Microencapsulation·Majid AfshariLeila Hosseinzadeh
Dec 25, 2008·Critical Reviews in Clinical Laboratory Sciences·Stefan Holdenrieder, Petra Stieber
Sep 30, 2009·Expert Opinion on Drug Metabolism & Toxicology·David James Hooker, Catherine Louise Cherry
Sep 11, 2012·Photodiagnosis and Photodynamic Therapy·Tamarisk Kerry HorneMarianne J Cronjé
Aug 18, 2009·Mutation Research·Akiko TamakoshiUNKNOWN JACC Study Group
Apr 23, 2009·European Journal of Pharmacology·Antonina Joanna MazurMaria Malicka-Błaszkiewicz
Jun 24, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Stefan HoldenriederPetra Stieber
Nov 4, 2015·Biochimica Et Biophysica Acta·Abel Jacobus BronkhorstPiet J Pretorius
Aug 12, 2008·Biochemical Pharmacology·Naghma KhanHasan Mukhtar
Aug 9, 2008·International Journal of Cancer. Journal International Du Cancer·Akiko TamakoshiUNKNOWN Japan Collaborative Cohort Study Group
Nov 17, 2006·Annals of the New York Academy of Sciences·Stefan HoldenriederPetra Stieber
Oct 8, 2008·Annals of the New York Academy of Sciences·Maniesh van der Vaart, Piet J Pretorius
Oct 8, 2008·Annals of the New York Academy of Sciences·Stefan HoldenriederPetra Stieber
Mar 31, 2011·Journal of Cellular Physiology·Michael FrezzaQ Ping Dou
Dec 9, 2004·Biochimica Et Biophysica Acta·Jeff CummingsCaroline Dive
Mar 6, 2015·Journal of Biosciences·Indraneel MittraAmit Dutt
Dec 31, 2014·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Zelinda HumanMarianne J Cronjé
Oct 22, 2016·Mutation Research·Ranjan BasakIndraneel Mittra
Nov 14, 2015·Journal of Biophotonics·Daniel M de BruinDirk J Faber
Mar 21, 2009·Expert Review of Molecular Diagnostics·Andreas E KremerStefan Holdenrieder
Sep 10, 2015·Biomedit︠s︡inskai︠a︡ khimii︠a︡·O E Bryzgunova, P P Laktionov
May 2, 2014·The Korean Journal of Thoracic and Cardiovascular Surgery·Andras Szasz
Jul 26, 2005·Clinical Chemistry·Stefan HoldenriederY M Dennis Lo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Andreas KremerD Seidel
Annals of the New York Academy of Sciences
Stefan Holdenrieder, Petra Stieber
International Journal of Cancer. Journal International Du Cancer
Stefan HoldenriederD Seidel
© 2022 Meta ULC. All rights reserved